Prognostic Performance of Inflammatory Biomarkers Based on Complete Blood Counts in COVID-19 Patients
Description
With the end of the pandemic, COVID-19 has entered an endemic phase with expected seasonal spikes. Consequently, the implementation of easily accessible prognostic biomarkers for patients with COVID-19 remains an important area of research. In this
